Literature DB >> 23332902

Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center.

Zhi-Ying Li1, Shen-Ju Gou, Min Chen, Ming-Hui Zhao.   

Abstract

OBJECTIVE: Anti-neutrophilcytoplasmic autoantibody (ANCA)-associated vasculitis may cause rapid deterioration of renal function, resulting in high prevalence of end-stage renal disease and mortality. The current study investigated factors associated with restoration of renal function and early mortality in patients with severe ANCA-associated glomerulonephritis, i.e. dialysis-dependent at presentation, in a single Chinese cohort.
METHODS: Eighty-nine Chinese patients with ANCA-associated glomerulonephritis who were on dialysis at the time of diagnosis were included in this study. All these patients received immunosuppressive therapy plus intravenous methylprednisolone, plasma exchange, or both. The predictive value of the clinical and histological parameters for renal and patient outcome was analyzed. RESULT: On the sixth month, 25 (28.1%) patients achieved dialysis independence, 45 (50.6%) patients progressed to end stage renal disease, and 19 (21.3%) patients died. Nine out of the 19 deaths were therapy-related. Factors independently associated with renal function restoration were percentages of normal glomeruli (P<0.05), extent of tubular atrophy (P<0.05) and extent of interstitial fibrosis (P<0.05) in the renal specimens. Age and pulmonary hemorrhage were independently associated with all-cause death (P=0.003 and P=0.007, respectively) and therapy-related death (P=0.037 and P=0.043, respectively).
CONCLUSIONS: Among patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation, those with a higher percentage of normal glomeruli and less extent of tubular atrophy/interstitial fibrosis have more chance of restoration of renal function. Increased risk for all-cause death and therapy-related death appears to be older age and pulmonary hemorrhage.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23332902     DOI: 10.1016/j.semarthrit.2012.09.005

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  16 in total

Review 1.  Histopathologic classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: achievements, limitations, and perspectives.

Authors:  Andrea Hinojosa-Azaola; Ariadna Jiménez-González
Journal:  Clin Rheumatol       Date:  2017-06-14       Impact factor: 2.980

2.  Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.

Authors:  Marta Casal Moura; Maria V Irazabal; Alfonso Eirin; Ladan Zand; Sanjeev Sethi; Bijan J Borah; Jeffrey L Winters; James P Moriarty; Rodrigo Cartin-Ceba; Alvise Berti; Misbah Baqir; Gwen E Thompson; Ashima Makol; Kenneth J Warrington; Viengneesee Thao; Ulrich Specks; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2020-08-21       Impact factor: 10.121

Review 3.  [S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis].

Authors:  Jan Henrik Schirmer; Peer M Aries; Kirsten de Groot; Bernhard Hellmich; Julia U Holle; Christian Kneitz; Ina Kötter; Peter Lamprecht; Ulf Müller-Ladner; Eva Reinhold-Keller; Christof Specker; Michael Zänker; Frank Moosig
Journal:  Z Rheumatol       Date:  2017-11       Impact factor: 1.372

4.  Late restoration of renal function in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation.

Authors:  Tian-Tian Ma; Yi-Ran Liu; Min Chen; Ming-Hui Zhao
Journal:  Clin Rheumatol       Date:  2018-04-20       Impact factor: 2.980

5.  Renal vasculitis presenting with acute kidney injury.

Authors:  Javier Villacorta; Francisco Diaz-Crespo; Mercedes Acevedo; Teresa Cavero; Carmen Guerrero; Manuel Praga; Gema Fernandez-Juarez
Journal:  Rheumatol Int       Date:  2017-03-13       Impact factor: 2.631

Review 6.  The Prevalence and Management of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China.

Authors:  Zhi-Ying Li; Tian-Tian Ma; Min Chen; Ming-Hui Zhao
Journal:  Kidney Dis (Basel)       Date:  2015-12-09

7.  Rituximab for treatment of severe renal disease in ANCA associated vasculitis.

Authors:  Duvuru Geetha; Zdenka Hruskova; Marten Segelmark; Jonathan Hogan; Matthew D Morgan; Teresa Cavero; Per Eriksson; Philip Seo; Rebecca L Manno; Jessica Dale; Lorraine Harper; Vladimir Tesar; David Rw Jayne
Journal:  J Nephrol       Date:  2015-05-19       Impact factor: 3.902

8.  Older patients with ANCA-associated vasculitis and dialysis dependent renal failure: a retrospective study.

Authors:  Rebecca L Manno; Philip Seo; Duvuru Geetha
Journal:  BMC Nephrol       Date:  2015-06-25       Impact factor: 2.388

9.  Persistent hematuria in patients with antineutrophil cytoplasmic antibody-associated vasculitis during clinical remission: chronic glomerular lesion or low-grade active renal vasculitis?

Authors:  Li Lv; Dong-Yuan Chang; Zhi-Ying Li; Min Chen; Zhao Hu; Ming-Hui Zhao
Journal:  BMC Nephrol       Date:  2017-12-06       Impact factor: 2.388

Review 10.  Concurrent pulmonary hemorrhage and deep vein thrombosis in a child with ANCA-associated vasculitis: case report and review of literature.

Authors:  Shi-Ting Tseng; Min-Hua Tseng; Jing-Long Huang
Journal:  Pediatr Rheumatol Online J       Date:  2015-06-10       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.